Working to Eradicate Gynecologic Cancers

Maria Bisogna, MS

Research Technician
Memorial Sloan Kettering Cancer Center
1275 York Avenue
New York, NY
USA 10065

Papers:
191 - Poster Session A PD-0332991, a cyclin-dependent kinase 4/6 inhibitor, is an active agent in uterine cancer cells